Body

Is endocan a novel marker of colorectal cancer?

Endocan, previously called endothelial cell specific molecule-1 (ESM-1), is over expressed in human tumors, and its serum levels are elevated in late-stage lung cancer and experimental tumor, as measured by enzyme-linked immunoassay or by immunohistochemistry. mRNA level of endocan is also recognized as one of the most significant molecular signatures with a poor prognosis of several types of cancer including lung cancer.

Does hypertriglyceridemia aggravate the episodes of severe acute pancreatitis?

HTG is a common clinical problem but rare cause of pancreatitis. It was reported that HTG is independently associated with the severity of AP and plays a role in the aggravation of acute necrotizing pancreatitis patients. However, the role of HTG in modulating disease course of

A research article to be published on July 28, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Xia from West China Hospital of Sichuan University investigated the effect of admission HTG on the episodes of SAP.

Extreme nature helps scientists design nano materials

Scientists are using designs in nature from extreme environments to overcome the challenges of producing materials on the nanometre scale. A team from the UK's John Innes Centre, the Scripps Research Institute in California and the Institut Pasteur in Paris have identified a stable, modifiable virus that could be used as a nanobuilding block.

Primary care records improve public health information

Gaining a fuller and more accurate picture of trends in the most important disease risk factors is now possible, thanks to a project between the NHS Information Centre and QResearch®.

The Public Health Indicators summary reports on trends in obesity, smoking, blood pressure, cholesterol and ethnicity using anonymous data taken from the health records of more than four million patients.

Filling in the blanks: Consumers want complete information to make choices

Most people don't like to make a purchase without complete information about the product they're buying. For example, if someone comparing wireless plans doesn't know the coverage area, she may be more likely to walk away from the purchase.

A new study in the Journal of Consumer Research examines the way consumers behave when information about a purchase is incomplete. Authors Kunter Gunasti and William T. Ross, Jr. (Pennsylvania State University) suggest that there are ways for marketers to reduce the number of customers who leave empty handed.

Why sufferers from Alzheimer's disease might have lower blood pressure

Oxford, October 14, 2008 - A new study (http://dx.doi.org/10.1016/j.bihy.2008.04.006) published in Bioscience Hypotheses (http://www.elsevier.com/locate/issn/1756-2392), a recently launched Elsevier journal, proposes that some people suffering from Alzheimer's disease experience a reduction in their high blood pressure because of cognitive decline.

Research says singling out sheep will save 1.3 million from lameness

New research from the University of Warwick published today in the journal BMC Veterinary Research suggests that a simple cheap individual approach to the care of sheep could slash the incidence of lameness in sheep saving 1.3 million sheep from lameness in the UK alone

More Americans have, get treated for high blood pressure

First, the bad news: More American adults have hypertension (high blood pressure) and prehypertension than ever before.

Now, the good news: The percentage of those getting treated for and controlling high blood pressure has also increased. As a result, even the bad news has a good news aspect: more people are living with rather than dying from hypertension.

What do you know? Not as much as you think

We've all met know-it-alls—people who think they know more than they actually do. If they're talking about products, like wine or motorcycles, they might actually know as much as they think. But when it comes to health plans, social policy, or nutrition, they might not, according to a new study in the Journal of Consumer Research.

AAT protein restores blood glucose in type 1 diabetes model

BOSTON – A protein made by the liver in response to inflammation and used to treat patients suffering from a genetic form of emphysema has been shown to restore blood glucose levels in a mouse model of Type 1 diabetes mellitus, according to a new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

Scientists develop new cancer-killing compound from salad plant

Researchers at the University of Washington have updated a traditional Chinese medicine to create a compound that is more than 1,200 times more specific in killing certain kinds of cancer cells than currently available drugs, heralding the possibility of a more effective chemotherapy drug with minimal side effects.

Celebrity adoption of charitable causes oversold

Los Angeles, London, New Delhi, Singapore and Washington DC (October 13, 2008) Celebrities do have the ability to focus awareness on charitable and political causes but their power to move the news machine to shape policy agendas has been oversold, according to recent research published by SAGE in the October issue of The International Journal of Press/Politics (IJPP).

Research confirms it: Noxious gas stove emissions worsen asthma symptoms in young children

Johns Hopkins scientists report that high levels of a noxious gas from stoves can be added to the list of indoor pollutants that aggravate asthma symptoms of inner-city children, especially preschoolers.

Nitrogen dioxide (NO2), an irritating and toxic form of nitrogen oxide gas, is most prevalent in industrial zones but also found at higher levels in poor homes with unvented gas stoves.

Why do women get more cavities than men?

Reproduction pressures and rising fertility explain why women suffered a more rapid decline in dental health than did men as humans transitioned from hunter-and-gatherers to farmers and more sedentary pursuits, says a University of Oregon anthropologist.

12-month ATLANTA trial data show sustained benefit of Catania Stent

WASHINGTON, Oct. 13 -- Clinical investigators at today's "Innovative Devices and Futuristic Therapies" session during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, presented 12-month follow-up data from the ATLANTA Trial. The results include zero percent thrombosis in patients discontinuing dual anti-platelet therapy after only 30 days.